focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.
Another tranche added for myself. We are now single digit trading days away from the gates opening to transformational newsflow.
By my readings of the relevant RNS it seems likely for s/s data confirmed & CE mark verified to be announced at the same time. My little brain is struggling to comprehend the potential financial figures that could roll in off the back of this.
Grab your final golden tickets.
Hi tsales, may be worth letting JP Morgan know that the boat has sailed for AVCT and all opportunity is gone as Aptamer are entering clinical trials!! Maybe give them a call to advise them to sell out of their newly upped position? They'll be hugely grateful that they missed this during their DD.
To all derampers, enjoy your next few (or less) days of fun. I'd perhaps look at doing some serious research into the figures at hand here - you may take a U-turn and invest heavily here.
Coincidently end of Q1 is a fantastic time to release big LFT news - plenty ISA accounts will be being topped up 6th April.
Ten trading days or less, have comfort in knowing there's going to be a sea of buys at whatever the price is when this news is imminent. A small retrace after a huge climb is healthy. It's just the psychology of seeing a) red and b) negativity spread makes you doubt your share acquisition - need not, we're a few days away from transformational news flow commencing.
Sangijuelas, likely the price I agree. If they were an employee from day-dot, pre-listing, then the template options agreement would likely be a very low amount (i.e. 0.001p per share is my current agreement for my company) to view positively.
Going to be a very happy cleaning team driving home in their Lambo's.. :- )
They have a right to exercise their options to buy, price could be any given amount even as low as £0.0001 per share.
Exercising now will release to them the physical shares at some point in the near future. Assume taxation benefit and also near-term news benefit; if they get the physical shares and catch any transformational news they can sell some, or all, if desired. For what may be a life changing amount of money for them!
Traders delight?
Limitation is the devil in the case of a nearing limitless global market opportunity. We are not, as such, bound by our manufacturing capabilities; our biggest boundary is how many LFD's can global manufacturers make for us? The 'unknown factor' in our case in regards to quantity is a huge positive, as this figure will only go North as more Governments, companies, manufacturers etc. enquire for a slice of a very versatile, very accurate and relatively cheap (given its selling points) LFD.
Not to serve as a de-ramp to ODX in any way, but in trying to understand the market this morning: they have a figure now (which is only going to increase and not decrease in the future, one would imagine) but it is, nonetheless, a figure which depicts their capability for manufacturing LFD's at this moment in time. A price has been put onto this. In AVCT's case no such figure can be painted, at least not currently, the SP is starting to reflect what's happening now and it will continue as such for a little while IMO. Investors are seeing much less risk and much more reward from every drop of news we see - we are now even seeing it in other companies RNS'!
It's quite astonishing the blue-sky potential we are seeing, not only in financials but in future-proofing our position in the BioTech sphere, potentially entire infrastructure being built to support us, in collaborative's..
This is also just one string of over a dozen large-scale opportunities at AVCT. Transformative.
I need another coffee. Might treat myself to my Lewak Coffee (just don't look up how it's made!). Have a good week, all!
Thank you all. Energy, it was actually a post of yours that took my eye enough to etch myself into the LSE user list, I have a very similar thought process r.e. S/S & CE.
All IMO - S/S is likely done, or at the very least the figures are all but confirmed and the 'big' RNS looks to be combining confirmation of both S/S & CE mark to open the gates to commercial/manufacturing specifics. We may be looking to go directly with our own CE Marking - with Mologic's there as back-up. Were we to mis-jump one hurdle in our own CE audit, the RNS we would need to lodge would be SP suicide - we currently have a fantastic safety net in place.
I'm astounded at the stubbornness for those willing to keep an eye on AVCT but actively shoot it down and wish it unwell, emotion is a funny thing, eh? AVCT are tied up with some huge whales in the BioTech ocean and have only recently hit the radar, some look back at the Q2-Q4 as a bit of a treacherous time to be a holder but it perversely is the most important catapult in AVCT's future. Huge strides.
I certainly wouldn't go to a board to try incite fear into holders nor defend such actions of someone doing so; not without at least a valid point of concern. I have held AVCT for just shy of a year and they'll need to be torn from me to not be holding for at least 5 more.
P.S. 'Sisu is a Finnish concept described as stoic determination, tenacity of purpose, grit, bravery, resilience, and hardiness'
The UK Gov won't entertain them because they have an undesired collection method. They are validated solely for posterior nasopharyngeal. Also you will need a healthcare professional to carry out such a test. Try harder please.